- About About
-
Medical
Medical
Medical Patient Resources Cannabis Care Certification Patient's Guide to Medical Cannabis Patient's Guide to CBD Talking to your doctor Become a Legal Medical Marijuana Patient The Medical Cannabis Patient’s Guide for U.S. Travel Guide to Using Medical Cannabis Cannabis Tincture, Salve, Butter and Oil Recipes Arthritis and Medical Cannabis Cancer and Medical Cannabis Chronic Pain and Medical Cannabis Gastrointestinal Disorders and Medical Cannabis HIV/AIDS and Medical Cannabis Movement Disorders and Medical Cannabis Multiple Sclerosis and Medical Cannabis Aging and Medical Cannabis Veterans and Medical Cannabis Medical Marijuana Conditions in Your Area Growing Cannabis Tracking Treatment & Gathering Data with Releaf App Medical Professional Resources Medical Cannabis Continuing Medical Education (CME) Cannabis Safety Medical Cannabis Research
- Legal Legal
-
Advocacy
Advocacy
Advocacy ASA Chapters Start an ASA Chapter Take Action Campaigns No Patient Left Behind End Pain, Not Lives Vote Medical Marijuana Medical Cannabis Advocate's Training Center Resources for Tabling and Lobby Days Strategic Planning Civics 101 Strategic Messaging Citizen Lobbying Participating in Implementation Movement Building Organizing a Demonstration Organizing Turnout for Civic Meetings Public Speaking Media 101 Patient's History of Medical Cannabis
-
Policy
Policy
Policy Policy Positions Model Federal Legislation Download Ending The Federal Conflict Public Comments by ASA Industry Standards Guide to Regulating Industry Standards Recognizing Science using the Data Quality Act Data Quality Act Briefs Fact Sheet on ASA's Data Quality Act Petition to HHS ASA Data Quality Act petition to HHS Information on Lawyers and Named Patients in the Data Quality Act Lawsuit Reports 2021 State of the States Cannabis and Cannabis Resin- Critical Review Preparation Document Medical Cannabis in America
- News News
- Join Join
-
-
The State of Medical Marijuana in South Dakota
2020 Grade: F
2015 | 2016 | 2017 | 2018-2019 | 2020 |
---|---|---|---|---|
F | F | F | F | F |
2019-2020 Improvements and Recommendations
Following the federal enactment of the 2018 Farm Bill and 2020 state enactment of HB 1008, South Dakota developed a draft regulatory approach to in-state hemp production that it submitted to FDA in June of 2020. Once USDA approves the plan HB 1008 authorizes in-state production of industrial hemp and CBD oil, finally allowing legal access to patients using CBD for treatment. Meanwhile constituents continue to organize and drive policy reforms in South Dakota. In November, voters will decide via Measure 26 on whether to authorize the creation of a comprehensive medical and adult-use legal access system.
Should the ballot measure prove unsuccessful, ASA recommends that South Dakota lawmakers initiate work in 2021 focused on building a comprehensive medical cannabis program. Such a program should provide legal protections to patients related to employment, housing, education and family law. The system should also authorize an in-state production system for lab-tested medical cannabis and cannabis products that can be made available to patients at legal retailers. ASA also recommends that lawmakers authorize patients to cultivate cannabis at home to reduce costs to patients.
Background
South Dakota is one of three states that has no form of medical cannabis access. In 2017, Mount Rushmore State lawmakers did secure enactment of legislation (SB 95) that excluded CBD from the state’s definition of marijuana, and downgraded CBD from Schedule I to Schedule IV on the state’s list of controlled substances. However, the new law did not authorize South Dakota hemp processors or CBD manufacturers to initiate production, provide for a licensing regime for these business activities, or establish a regulated patient access and registry regime. Instead, South Dakota only permitted the sale of CBD that has been authorized for use by the U.S. Food and Drug Administration (FDA).
Patient Feedback
No feedback was received from patients in North Dakota.
Share